<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since its discovery in the early 1990s the deleted in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:chebi fb="8" ids="53090">DCC</z:chebi>) gene, located on chromosome 18q21, has been proposed as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor gene as its loss is implicated in the majority of advanced colorectal and many other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="8" ids="53090">DCC</z:chebi> belongs to the family of netrin 1 receptors, which function as dependence receptors as they control survival or <z:mpath ids='MPATH_3'>apoptosis</z:mpath> depending on ligand binding </plain></SENT>
<SENT sid="2" pm="."><plain>However, the role of <z:chebi fb="8" ids="53090">DCC</z:chebi> as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor remains controversial because of the rarity of <z:chebi fb="8" ids="53090">DCC</z:chebi>-specific mutations and the presence of other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor genes in the same chromosomal region </plain></SENT>
<SENT sid="3" pm="."><plain>Here we show that in a mouse model of <z:mp ids='MP_0001883'>mammary carcinoma</z:mp> based on somatic inactivation of p53, additional loss of <z:chebi fb="8" ids="53090">DCC</z:chebi> promotes <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> formation without affecting the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> phenotype </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, we demonstrate that in cell cultures derived from p53-deficient mouse <z:e sem="disease" ids="C1458155" disease_type="Neoplastic Process" abbrv="">mammary tumours</z:e> <z:chebi fb="8" ids="53090">DCC</z:chebi> expression controls netrin-1-dependent cell survival, providing a mechanistic basis for the enhanced metastatic capacity of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells lacking <z:chebi fb="8" ids="53090">DCC</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Consistent with this idea, in vivo <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-cell survival is enhanced by <z:chebi fb="8" ids="53090">DCC</z:chebi> loss </plain></SENT>
<SENT sid="6" pm="."><plain>Together, our data support the function of <z:chebi fb="8" ids="53090">DCC</z:chebi> as a context-dependent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor that limits survival of disseminated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells </plain></SENT>
</text></document>